期刊文献+

血清趋化素及肿瘤坏死因子α水平与2型糖尿病肾脏病的相关性研究 被引量:8

Association of serum chemerin,tumor necrosis factor-α and type 2 diabetic kidney disease
下载PDF
导出
摘要 目的观察不同分期糖尿病肾脏病(diabetic kidney disease,DKD)患者血清趋化素(chemerin)及肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)水平的变化,并探讨其与DKD的相关性。方法入选45名健康体检者作为正常对照(normal control,NC)组和133例2型糖尿病患者,后者根据尿微量白蛋白/肌酐(the value of urinary albumin/creatine ratio,ACR)水平分为单纯糖尿病(simple diabetes mellitus,SDM)组47例、微量白蛋白尿(micro albuminuria DKD,mic-DKD)组41例和大量白蛋白尿(macro albuminuria DKD,mac-DKD)组45例。采用ELISA法测定4组研究对象的血清chemerin和TNF-α水平,并分析DKD发生的危险因素。结果 NC组血清chemerin浓度为(34.14±7.54)ng/ml,TNF-α浓度为(103.99±20.43)ng/L。SDM组血清chemerin浓度为(38.23±5.48)ng/ml,TNF-α浓度为(134.42±27.31)ng/L。mic-DKD组血清chemerin浓度为(42.69±8.os)ng/ml,TNF-α浓度为(165.48±32.63)ng/L。mac-DKD组血清chemerin浓度为(47.32±9.11)ng/ml,TNF-α浓度为(227.53±58.31)ng/L。4组血清chemerin和TNF-α水平逐渐升高,组间比较差异具有统计学意义(均P<0.05)。血清chemerin水平与TNF-α、超敏C反应蛋白(high sensitivity C-reactive protein,hs-CRP)、糖化血红蛋白(glycosylated hemoglobin,HbA1c)、血肌酐(SCr)及病程呈正相关,与高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)呈负相关。血清TNF-α水平与尿ACR、HbA1c、hs-CRP、SCr、低密度脂蛋白胆固醇(ligh-density lipoprotein cholesterol,LDL-C)及病程呈正相关,与HDL-C呈负相关。Logistic回归分析显示,chemerin、TNF-α、白细胞、年龄、HbA1c、低HDL-C及高血压是DKD发生的独立危险因素。结论 Chemerin和TNF-α参与了DKD发病,检测其水平可以在一定程度上反映DKD病情的严重程度。 Objective To examine the level of serum chemerin and TNF-α in different stages of type 2 diabetic kidney disease (DKD) patients and explore the pathogenesis of DKD. Methods Forty- five normal subjects (NC group) and 133 patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. The T2DM patients were divivded into three subgroups: simple T2DM (SDM) group (n = 47), microalbuminuria (mic-DKD) group (n = 41) and macroalbuminuria (mac-DKD) group (n = 45) according to the urinary albumin creatinine ratio. The levels of serum chemerin and TNF-α were determined by ELISA. Logistic regession model was used to analyze the risk factors of DKD. Results Serum chemerin concentration and serum TNF-α concentration in NC group, SDM group, mic-DKD group and mac-DKD group were (34. 14 ± 7. 54), (38. 23 ± 5. 48), (42. 69 ± 8. 05) and (47. 32 ± 9. 11) ng/ml, and (103.99±20.43),(134.42±27.31), (165.48±32.63) and (227.53±58.31) ng/L, respectively. The levels of chemerin and TNF-α were increased gradually from NC group, SDM group, mic-DKD group to mac-DKD group with the difference being statistically significant between each two groups (all P〈0. 05). The serum chemerin was positively correlative with TNF-α, hs-CRP, HbAlc, SCr and duration, but negatively correlated with FIDL-C. The serum TNF-α was positively correlated with urinary ACR, HbAlc, hs-CRP, SCr, LDL-C and duration, but negatively correlated with HDL-C. Logistic regression analysis revealed that chemerin, TNF-α, WBC, age, FIbAlc, lower FIDL-C and hypertension were independent risk factors of DKD. Conclusions Chemerin and TNF-α were involved in the pathogenesis of DKD, and their levels may reflect a degree of severity for DKD.
出处 《临床肾脏病杂志》 2016年第3期162-167,共6页 Journal Of Clinical Nephrology
关键词 趋化素 肿瘤坏死因子Α 超敏C反应蛋白 Chemerin Tumor necrosis factor alpha High sensitivity C-reactive protein
  • 相关文献

参考文献9

二级参考文献122

  • 1李伶,杨刚毅.脂代谢紊乱和脂肪细胞因子与胰岛素抵抗[J].中国糖尿病杂志,2007,15(3):129-131. 被引量:41
  • 2Wada T, Furuiehi K, Sakai N, et al. Up-regulation of MCP 1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int, 2000,58 : 1492-1499. 被引量:1
  • 3Tam FW, Riser BL, Meeran K, et al. Urinary monocyte chemoat- tractant protein-I (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic ne- phropathy. Cytokine, 2009,47 .. 37-42. 被引量:1
  • 4Morii T,Fujita H, Narita T, et al. Association of monocyte che- moattractant protein-1 with renal tubular damage in diabetic ne- phropathy. J Diabetes Complications, 2003,17 : 11-15. 被引量:1
  • 5Chow Y, Nikolic-Paterson DJ, Ozots E, et al. Monocyte chemoat- tractant protein-1 promotes the development of diabetic renal in- jury in streptozotocin-treated mice. Kidney Int, 2006,69.. 73-80. 被引量:1
  • 6Jiao B, Wang YS, Cheng YN, et aL Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-131 expression in glomerular mesangial and epithelial cells induced by high-glucose levels. Bio- sci Trends, 2011,5 : 173-18 l. 被引量:1
  • 7Tang SC, Chan LY, Leung JC, et al. Differential effects of ad- vanced glycation end-products on renal tubular cell inflamma- tion. Nephrology(Carlton), 2011,16 : 417-425. 被引量:1
  • 8Gu L, Hagiwara S, Fan Q, et al. Role of receptor for advanced glycation end-products and signalling events in advanced glyca- tion end-product-induced monocyte chemoattractant protein-1 ex- pression in differentiated mouse podocytes. Nephrol Dial Trans-plant, 2006,21 : 299-313. 被引量:1
  • 9Sayyed SG, Ryu M, Kulkarni OP, et al. An orally active chemo- kine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int, 2011,80 : 68-78. 被引量:1
  • 10Kang YS, Lee MH, Song HK, et al. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int,2010,78:883-894. 被引量:1

共引文献6879

同被引文献93

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部